References
- Lewis, E J.; Hunsicker, L G.; Bain, R P.; Rohde, R D.; for The Collaborative Study Group. The effect of angiotensin converting enzyme inhibition on diabetic nephropethy. N. Engl. J. Med. 1993, 329, 1456–1462. [PUBMED], [INFOTRIEVE], [CSA]
- Ruggenti, P.; Perna, A.; Gherardi, G.; , et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999, 354, 359–364. [CSA], [CROSSREF]
- The GISEN Group. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric non-diabetic nephropathy. Lancet 1997, 349, 1857–1863. [CSA], [CROSSREF]
- Brenner, B M.; Cooper, M E.; De Zeeuw, D.; , et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001, 345, 861–869. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lewis, E J.; Hunsicker, L G.; Clarke, W R.; Collaborative Study Group; , et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 2001, 345, 851–860. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hayashi, T.; Suzuki, A.; Shoji, T.; , et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am. J. Kidney Dis. 2000, 35, 250–256. [PUBMED], [INFOTRIEVE], [CSA]
- Attman, P.-O.; Alaupovic, P. Lipid abnormalities in chronic renal insufficiency. Kidney Int. 1991, 39, S16–S23. [CSA]
- Pitts, T O.; Piraino, B H.; Mitro, R.; , et al. Hyperparathyroidism ans 1,25-dihydroxyvitamin D deficiency in mild, moderate and severe renal failure. J. Clin. Endocrinol. Metab. 1988, 67, 876–881. [PUBMED], [INFOTRIEVE], [CSA]
- Nissenson, A R.; Collins, A J.; Hurley, J.; Petersen, H.; Pereira, B J.; Steinberg, E P. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J. Am. Soc. Nephrol. 2001, 12, 1713–1720. [PUBMED], [INFOTRIEVE], [CSA]
- Kausz, A T.; Khan, S S.; Abichandani, R.; , et al. Management of patients with chronic renal insufficiency in the Northeastern United States.. Am. Soc. Nephrol. 2001, 12, 1501–1507. [CSA]
- Obrador, G T.; Roberts, T.; St. Peter, W L.; Frazier, E.; Pereira, B J.; Collins, A. Trends in anemia management in the United States. Kidney Int. 2001, 60, 1875–1884. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- London, R.; Solis, A.; Goldberg, G A.; Wade, S.; Ryu, S. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am. J. Kidney Dis. 2002, 40, 539–548. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Israni, A.; Korzelius, C.; Townsend, R.; Mesler, D. Management of chronic kidney disease in an academic primary care clinic. Am. J. Nephrol. 2003, 23, 47–54. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jacobson, H R.; Striker, G E. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am. J. Kidney Dis. 1995, 25, 103–106. [PUBMED], [INFOTRIEVE], [CSA]
- National Kidney Foundation. DOQI Clinical Guidelines for the treatment of anemia of chronic renal failure. Am. J. Kidney Dis. 1997, 30 (Suppl. 3), s192–s240. [CSA]
- Coburn, J W.; Elangovan, L. Prevention of metabolic bone disease in the pre-end-stage renal disease setting. J. Am. Soc. Nephrol. 1998, 9, s71–q77. [PUBMED], [INFOTRIEVE], [CSA]
- Kiberd, B A.; Clase, C M. Cumulative risk for developing end-stage renal disease in the US population. J. Am. Soc. Nephrol. 2002, 13, 1635–1644. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- National Kidney Foundation. K/DOQI clinical guidelines for chronic kidney disease: evaluation, classification, and stratification, Part 1; executive summary. Am. J. Kidney Dis. 2002, 39 (Suppl. 1), s14–s266., [CSA]
- Kazmi, W H.; Kausz, A T.; Khan, S.; , et al. Anemia: an early complication of chronic renal insufficiency. Am. J. Kidney Dis. 2001, 38, 803–812. [PUBMED], [INFOTRIEVE], [CSA]
- US Renal Data System. USRDS 2000 Annual Data Report; National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases: Bethesda, MD, 2000.
- National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis. 2003, 42 (Suppl. 3), s7–s201. [CSA]